Inhibrx Biosciences Inc (INBX)
R&D Expenses
$102.47M
TTM · Period ending: · USD
INBX R&D Expenses
Latest reported$102.47Mperiod ending
Latest reported$102.47Mperiod ending
INBX R&D Expenses ($16.99M → $102.47M)
Annual R&D Expenses
High-resolution chart · PNG
INBX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 113,028,000 | |
| 203,743,000 | |
| 190,648,000 | |
| 110,186,000 | |
| 71,440,000 | |
| 73,495,000 | |
| 47,907,000 | |
| 33,454,000 | |
| 25,510,000 | |
| 16,992,000 |